Adverum Biotechnologies, Inc.
-
Ticker
ADVM
-
Industry
Biotechnology More
-
Sector
Healthcare More
- 51-200 Employees
- Based in Redwood City, California
Adverum is a gene therapy company advancing novel medicines that can offer life-changing benefits to patients living with serious rare and ocular diseases. Adverum has a robust pipeline that includes product candidates designed to treat wet age-related macular degeneration (wAMD) and rare diseases alpha-1 antitrypsin (A1AT) deficiency and hereditary angioedema (HAE).
Adverum Biotechnologies, Inc.
Most Recent Responsibility Report
Our service enables potential investors to review the most recent and archived Adverum Biotechnologies, Inc. Sustainability Report, Adverum Biotechnologies, Inc. Corporate Social Responsibility Report, Adverum Biotechnologies, Inc. CSR Report, Adverum Biotechnologies, Inc. Corporate Responsibility, Adverum Biotechnologies, Inc. CR Report, Adverum Biotechnologies, Inc. Citizenship Report, Adverum Biotechnologies, Inc. ESG Report, and Adverum Biotechnologies, Inc. Environmental Report online.